This report describes the global market size of Pharmaceutical Dissolution Testing from 2019 to 2022 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2031 and its expected to grow with a CAGR of 30.5% from 2024 to 2031.
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Pharmaceutical Dissolution Testing estimated at US $6.25Billion in the year 2022, is projected to reach a revised size of US $ 1,374.15 Billion by 2031, growing at a CAGR of 30.5% during the forecast period 2024-2031.
Pharmaceutical dissolution testing is a laboratory process used to measure the rate and extent at which a drug is released from its dosage form (e.g., tablet or capsule) and dissolved in a liquid medium, typically mimicking bodily fluids. This test is crucial in evaluating the bioavailability of a drug, ensuring that it releases its active ingredients at the appropriate rate to achieve therapeutic effects. Dissolution testing helps pharmaceutical companies assess the consistency of drug batches, optimize formulations, and meet regulatory standards. It also plays a significant role in drug development, stability testing, and quality control. By simulating in vivo conditions, dissolution testing provides insight into how a drug will behave in the human body, making it a critical tool for ensuring the safety and efficacy of medications.
For geography segment, regional supply, demand, major players, price is presented from 2019 to 2031. This report cover following regions:
North America
Asia-Pacific
Europe
Middle East and Africa
South America
The key countries for each regions are also included such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.
For competitor segment, the report include global key players of Pharmaceutical Dissolution Testing as well as some small players. The information for each competitor include:
Company Profile
Main Business Information
SWOT Analysis
Sales Volume, Revenue, Price and Gross Margin
Market Share
By Dosage Form
Capsules
Tablets
Others
In pharmaceutical dissolution testing, different dosage forms require tailored approaches to ensure accurate assessment of drug release. Capsules are a common dosage form, often containing powders, liquids, or granules encased in a gelatin shell, and dissolution testing evaluates how quickly the shell dissolves and releases the active ingredients. Tablets, being solid, compressed forms, require dissolution testing to ensure the tablet breaks down properly in the body, releasing the drug at the intended rate for optimal absorption. Both capsules and tablets undergo dissolution testing to meet regulatory requirements and ensure consistent drug performance. Other dosage forms, such as powders, lozenges, or extended-release forms, are also subject to dissolution testing, depending on their composition and intended release profiles. Testing for each dosage form ensures that medications deliver therapeutic benefits effectively and safely.
By Dissolution Apparatus
Basket
Paddle
Fillers and syringh
Dissolution Media
Others
In pharmaceutical dissolution testing, various dissolution apparatus are used to simulate in vivo conditions and assess how quickly and completely a drug dissolves. The Basket apparatus is commonly used for testing solid dosage forms like capsules and tablets, where the drug is placed in a rotating mesh basket submerged in a dissolution medium. The Paddle apparatus uses a stirring paddle to agitate the medium, ensuring the drug dissolves evenly and consistently. Fillers and syringes are employed to measure and handle the dissolution medium, ensuring precise volumes and accurate sample collection during testing. Dissolution media, such as buffers or simulated gastric fluids, mimic the environment inside the human body, providing realistic conditions for drug release. Other apparatus and methods include specialized tools for testing different dosage forms or ensuring controlled release in extended-release formulations. Together, these apparatus and techniques provide a standardized way to evaluate drug dissolution and ensure consistent therapeutic performance.
By End User
Pharmaceutical Companies
Contract Research Organizations (CROs)
Academic and Research Institutions
Regulatory Laboratories
In pharmaceutical dissolution testing, various end users rely on the process for ensuring drug quality, efficacy, and compliance. Pharmaceutical companies are the primary users, conducting dissolution tests during drug development, formulation optimization, and quality control to ensure that their products meet regulatory standards for bioavailability and release profiles. Contract Research Organizations (CROs) perform dissolution testing on behalf of pharmaceutical companies, offering specialized expertise and outsourcing services for drug development, testing, and clinical trials. Academic and research institutions utilize dissolution testing for scientific studies, focusing on understanding drug release mechanisms, improving formulations, and contributing to pharmaceutical research. Regulatory laboratories, such as those operated by government agencies like the FDA or EMA, use dissolution testing to verify compliance with regulations, ensuring that drugs released to the market meet safety and efficacy standards. These diverse end users rely on dissolution testing as a key tool in the development, approval, and continuous monitoring of pharmaceutical products.
By Key Players
Intertek Group Plc.
Avivia BV
Almac Group
Agilent Technologies, Inc.
Catalent, Inc.
Thermofisher Scientific Inc.
Cambrex Corp.
Charles River Laboratories
Boston Analytical
Pace Analytical Life Sciences
SOTAX
AMRI
SGS SA
Please ask for sample pages for full companies list
Base Year: 2023
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2031
Any special requirements about this report, please let us know and we can provide custom report.
Your phrase has been sent to nick's email. Once he takes action. you will be notified!
Stats And Research ™ Copyright © 2025 .